4
Total investments
1
Early stage
1
Mid stage
2
Late stage
6y
Years active
Portfolio
4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Sep 2023
At Whitebox we produce single serve classic cocktails so that you can enjoy a world class cocktail in a few seconds, wherever you are.
Seed Investor
Dec 2022
Occuitys mission is to improve the lives of hundreds of millions of people by developing painless, contact-free screening & monitoring solutions for health conditions such as #diabetes, #myopia, #glaucoma and #Alzheimers Disease.
Occuity is a UK-based medical technology company specialising in the research, design, and production of handheld non-contacting optical instruments for use in healthcare, diagnostics, and monitoring. Occuity’s scanning technology uses light to obtain precise measurements of different structures within the eye. This will enable direct measurements of the eye for optometrists and ophthalmologists but also other more general health conditions such as diabetes and Alzheimer’s Disease to be monitored.
Occuitys IP includes 9granted international patents with a further 5 applications.
Our Products
Optometry & Ophthalmology:
Were designing and developing a range of handheld, optical non-contacting devices. Our first device will be the world’s first handheld, non-contacting optical pachymeter – The Occuity PM1 – due to launch in 202.
The underlying technology in the PM1 will be built upon to look at other measurements within the eye including, axial length, pupillometry and keratometry for use in both human and veterinary optometry.
Disease Screening
Building upon our patented technology, Occuitys disease screening products, will make it easier and cheaper to screen for diseases such as diabetes and Alzheimers in non-clinical settings such as high street opticians, pharmacies and care homes.
Disease Monitoring
Occuity’s vision is to deliver the world’s first non-invasive, non-contacting glucose monitor.
Instead of relying on finger stick blood tests to provide blood glucose readings, Occuity is in the process of researching & developing a non-contact handheld optical device to determine the blood glucose level by measuring subtle changes within the anterior chamber of the eye.
Investor
Dec 2020
Urban is the wellness app for busy people. It’s a way to book massages, beauty treatments, Osteopathy and more to your home or office.
For busy professionals in the city, it’s a one-stop-shop for relaxation and self-care that fits easily into any schedule. And for the pros using Urban to connect with clients, it’s a new way to earn more working to their own hours and on their own terms. A win-win, if there ever was one.
Experience · 6 entries
All (6)
Investments (4)
Founder (1)
2026
Community Ambassador for the Female Founder Hub
May 2026
Enterprise Nation was founded in 2005 by Emma Jones MBE. Whether you’re launching a new business or developing an existing one, Enterprise Nation connects you to the resources to help you succeed.
2023
Investor
Sep 2023
At Whitebox we produce single serve classic cocktails so that you can enjoy a world class cocktail in a few seconds, wherever you are.
2022
Partnerships Manager
Dec 2022
Purpose driven companies grow three times faster than their competitors. We specialise in enabling brands to develop and communicate their social purpose and make a positive difference in the world.
From discovery workshops to omni-channel campaign production, Verity London supports brands to clarify and share their purpose messaging and embed it into the heart of their organisation.
If you’re looking to develop deeper relationships with employees and consumers, drive societal change and build sustainable growth, we want to hear from you.
Seed Investor
Dec 2022
Occuitys mission is to improve the lives of hundreds of millions of people by developing painless, contact-free screening & monitoring solutions for health conditions such as #diabetes, #myopia, #glaucoma and #Alzheimers Disease.
Occuity is a UK-based medical technology company specialising in the research, design, and production of handheld non-contacting optical instruments for use in healthcare, diagnostics, and monitoring. Occuity’s scanning technology uses light to obtain precise measurements of different structures within the eye. This will enable direct measurements of the eye for optometrists and ophthalmologists but also other more general health conditions such as diabetes and Alzheimer’s Disease to be monitored.
Occuitys IP includes 9granted international patents with a further 5 applications.
Our Products
Optometry & Ophthalmology:
Were designing and developing a range of handheld, optical non-contacting devices. Our first device will be the world’s first handheld, non-contacting optical pachymeter – The Occuity PM1 – due to launch in 202.
The underlying technology in the PM1 will be built upon to look at other measurements within the eye including, axial length, pupillometry and keratometry for use in both human and veterinary optometry.
Disease Screening
Building upon our patented technology, Occuitys disease screening products, will make it easier and cheaper to screen for diseases such as diabetes and Alzheimers in non-clinical settings such as high street opticians, pharmacies and care homes.
Disease Monitoring
Occuity’s vision is to deliver the world’s first non-invasive, non-contacting glucose monitor.
Instead of relying on finger stick blood tests to provide blood glucose readings, Occuity is in the process of researching & developing a non-contact handheld optical device to determine the blood glucose level by measuring subtle changes within the anterior chamber of the eye.
2020
Investor
Dec 2020
Urban is the wellness app for busy people. It’s a way to book massages, beauty treatments, Osteopathy and more to your home or office.
For busy professionals in the city, it’s a one-stop-shop for relaxation and self-care that fits easily into any schedule. And for the pros using Urban to connect with clients, it’s a new way to earn more working to their own hours and on their own terms. A win-win, if there ever was one.
Show all 6 entries ↓
Investment activity
2020–2023 · 4 investments
Recent (last 2 years)Earlier
